A new digital/pharma partnership. Amid a breakdown of its new strategic direction, Paris-based Voluntis announced a new partnership with Bristol-Myers Squibb that aims to support cancer patients with a new digital-therapeutic platform. Patients would use this app-based tool to track their symptoms and treatment, while also being provided with relevant self-management recommendations via an...
